Tighter Testing New Normal For US OTC Sanitizer Firms Due To Contaminations During Pandemic
With higher demand a norm, OTC sanitizer firms should do the same with scrutiny of their supplies of alcohol and other ingredients. “The market itself will always be much higher than a pre-COVID level as it’s a consumer product that is going to be used on a more regular basis,” says Ed Wyszumiala, head of US Pharmacopeia’s verification program.
You may also be interested in...
US Still Rinsing Out OTC Sanitizer Warnings
Of GMP warnings for OTC hand sanitizers, 114 have been submitted by FDA since pandemic began, with first sent in late April 2020, and another 12 for false COVID-19 claims, with first sent on 1 April. One GMP warning for hand sanitizer product is listed in both 2018 and 2019.
COVID-19: US Regulators Continue Enforcement, FDA Commissioner Califf Has Positive Test Results
Califf experiencing mild symptoms after testing positive for COVID-19. FDA and FTC continue finding coronavirus-related fraud in consumer health products market.
End Is Near For Distributing OTC Hand Sanitizers Manufactured Under Temporary US Guidance
The 31 March cut-off date brings to a comparatively low-profile end a well-chronicled saga of FDA acting to increase OTC hand sanitizer production as consumer demand soared in response to COVID-19.